GGrantIndex
Sort

25,944 grants matching neurodegeneration

Integrative Chemical Biology of Neurodegeneration: Foundation to Novel Therapies

$264,250
D. Martin Watterson · Northwestern University At Chicago · R01 · FY2008 · NS

Integrative Chemical Biology of Neurodegeneration: Foundation to Novel Therapies

$264,250
D. Martin Watterson · Northwestern University At Chicago · R01 · FY2009 · NS

O-GlcNAcylation of tau: a link between glucose metabolism and neurodegeneration

$264,213
Cheng-Xin Gong · Institute For Basic Res In Dev Disabil · R01 · FY2009 · AG

Beclin 1 Neurodegeneration and Alzheimer's Disease

$264,204
Tony Wyss-Coray · Palo Alto Veterans Instit For Research · R01 · FY2009 · AG

Structure and Function of Cytoplasmic Dynein

$264,005
Thomas S Hays · University Of Minnesota · R01 · FY2010 · GM

Adenosine, Glutamate and Neurodegeneration

$263,936
Patricia K Sonsalla · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2006 · NS

Oral N-Acetylglucosamine as Anti-Neuroinflammatory Add-on therapy for Multiple Sclerosis (NANA-MS)

$263,892
Michael Demetriou · University Of California-Irvine · R34 · FY2025 · AI

Mechanisms of Intercellular Communication

$263,872
Albert Einstein Col Of Med Yeshiva Univ · T32 · FY2005 · NS

Time-lines of neural degeneration in ALS-PDC mouse model

$263,859
Christopher A Shaw · University Of British Columbia · R01 · FY2007 · NS

Nitrosylation of Cytochrome C during Apoptosis

$263,832
Joan B Mannick · Univ Of Massachusetts Med Sch Worcester · R01 · FY2007 · GM

A model of TRPV4 channelopathy

$263,789
Charlotte Jane Sumner · Johns Hopkins University · R21 · FY2014 · NS

Macrophage Gene Therapy of Neurodegenerative Diseases

$263,753
Senlin Li · University Of Texas Hlth Science Center · R01 · FY2006 · NS

Pathogenic Mechanisms in Tauopathy Development and Potential Use of Therapeutics

$263,723
Karen E Duff · Nathan S. Kline Institute For Psych Res · P01 · FY2006 · NS

Administrative Core

$263,591
Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2023 · AG

AB AND IL - 1B SUPPRESS BDNF SIGNALING AND THE REGULATION OF SYNAPTIC PLASTICITY

$263,545
Carl W Cotman · University Of California-Irvine · P01 · FY2010 · AG

DROSOPHILA MODELS FOR PARKINSON'S DISEASE

$263,532
Nancy M Bonini · University Of Pennsylvania · P01 · FY2006 · AG

Neuron regenerative therapeutic, NNI-362, for first-in-human safety and PK for AD

$263,516
Judith A Kelleher-Andersson · Neuronascent, Inc. · R01 · FY2019 · AG

Xenobiotic Biotransformation in Down Syndrome

$263,457
James R Roede · University Of Colorado Denver · R01 · FY2018 · ES

Shifting auditory spatial attention: cognitive and neural mechanisms

$263,449
Edward J Golob · University Of Texas San Antonio · R01 · FY2019 · DC

Administrative Core

$263,421
Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2022 · AG

Administrative Core

$263,421
Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2021 · AG

Molecular Mechanisms of Cytoskeletal Regulators

$263,367
Kevin C Slep · Univ Of North Carolina Chapel Hill · R01 · FY2013 · GM

Neurotrophin Protection in HIV and Aging

$263,340
Rick B Meeker · Univ Of North Carolina Chapel Hill · R01 · FY2014 · NS

CORE C: Neuropathology & Genetics Core

$263,330
John Q. Trojanowski · University Of Pennsylvania · P50 · FY2017 · NS

Structure and Genesis of tau Aggregates

$263,276
Jeff A Kuret · Ohio State University · RF1 · FY2020 · AG